Diagnosis and treatment of Friedreich ataxia: a European perspective (original) (raw)

• Campuzano, V. et al. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271, 1423–1427 (1996).
  CAS PubMed Google Scholar
• Labuda, M. et al. Unique origin and specific ethnic distribution of the Friedreich ataxia GAA expansion. Neurology 54, 2322–2324 (2000).
  CAS PubMed Google Scholar
• Cossee, M. et al. Evolution of the Friedreich's ataxia trinucleotide repeat expansion: founder effect and premutations. Proc. Natl Acad. Sci. USA 94, 7452–7457 (1997).
  CAS PubMed PubMed Central Google Scholar
• Epplen, C. et al. Differential stability of the (GAA) tract in the Friedreich ataxia (STM7) gene. Hum. Genet. 99, 834–836 (1997).
  CAS PubMed Google Scholar
• Juvonen, V. et al. Dissecting the epidemiology of a trinucleotide repeat disease—example of FRDA in Finland. Hum. Genet. 110, 36–40 (2002).
  CAS PubMed Google Scholar
• Polo, J. M. et al. Hereditary ataxias and paraplegias in Cantabria, Spain. An epidemiological and clinical study. Brain 114, 855–866 (1991).
  PubMed Google Scholar
• Wintermeyer, P. et al. Mutation analysis and association studies of the UCHL1 gene in German Parkinson's disease patients. NeuroReport 11, 2079–2082 (2000).
  CAS PubMed Google Scholar
• Werdelin, L. & Keiding, N. Hereditary ataxias: epidemiological aspects. Neuroepidemiology 9, 321–331 (1990).
  CAS PubMed Google Scholar
• Skre, H. Friedreich's ataxia in western Norway. Clin. Genet. 7, 287–298 (1975).
  CAS PubMed Google Scholar
• Jonasson, J. et al. Evidence for a common spinocerebellar ataxia type 7 (SCA7) founder mutation in Scandinavia. Eur. J. Hum. Genet. 8, 918–922 (2000).
  CAS PubMed Google Scholar
• Colombo, R. & Carobene, A. Age of the intronic GAA triplet repeat expansion mutation in Friedreich ataxia. Hum. Genet. 106, 455–458 (2000).
  CAS PubMed Google Scholar
• Richards, M. et al. Tracing European founder lineages in the near Eastern mtDNA pool. Am. J. Hum. Genet. 67, 1251–1276 (2000).
  CAS PubMed PubMed Central Google Scholar
• Semino, O. et al. The genetic legacy of Paleolithic Homo sapiens sapiens in extant Europeans: a Y chromosome perspective. Science 290, 1155–1159 (2000).
  CAS PubMed Google Scholar
• Tambets, K. et al. The western and eastern roots of the Saami—the story of genetic “outliers” told by mitochondrial DNA and Y chromosomes. Am. J. Hum. Genet. 74, 661–682 (2004).
  CAS PubMed PubMed Central Google Scholar
• Montermini, L. et al. The Friedreich ataxia GAA triplet repeat: premutation and normal alleles. Hum. Mol. Genet. 6, 1261–1266 (1997).
  CAS PubMed Google Scholar
• Harding, A. E. Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain 104, 589–620 (1981).
  CAS PubMed Google Scholar
• Fahey, M. C. et al. Vestibular, saccadic and fixation abnormalities in genetically confirmed Friedreich ataxia. Brain 131, 1035–1045 (2008).
  PubMed Google Scholar
• Givre, S. J. et al. Visual loss and recovery in a patient with Friedreich ataxia. J. Neuroophthalmol. 20, 229–233 (2000).
  CAS PubMed Google Scholar
• Ell, J. et al. Neuro-otological abnormalities in Friedreich's ataxia. J. Neurol. Neurosurg. Psychiatry 47, 26–32 (1984).
  CAS PubMed PubMed Central Google Scholar
• Rance, G. et al. Speech perception ability in individuals with Friedreich ataxia. Brain 131, 2002–2012 (2008).
  PubMed Google Scholar
• Trouillas, P. et al. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J. Neurol. Sci. 145, 205–211 (1997).
  CAS PubMed Google Scholar
• Subramony, S. H. et al. Measuring Friedreich ataxia: interrater reliability of a neurologic rating scale. Neurology 64, 1261–1262 (2005).
  CAS PubMed Google Scholar
• Fahey, M. C. et al. How is disease progress in Friedreich's ataxia best measured? A study of four rating scales. J. Neurol. Neurosurg. Psychiatry 78, 411–413 (2007).
  CAS PubMed Google Scholar
• Schmitz-Hübsch, T. et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 66, 1717–1720 (2006).
  PubMed Google Scholar
• Lynch, D. R. et al. Measuring Friedreich ataxia: complementary features of examination and performance measures. Neurology 66, 1711–1716 (2006).
  CAS PubMed Google Scholar
• Dürr, A. et al. Clinical and genetic abnormalities in patients with Friedreich's ataxia. N. Engl. J. Med. 335, 1169–1175 (1996).
  PubMed Google Scholar
• Montermini, L. et al. Phenotypic variability in Friedreich ataxia: role of the associated GAA triplet repeat expansion. Ann. Neurol. 41, 675–682 (1997).
  CAS PubMed Google Scholar
• Ulku, A. et al. Friedreich's ataxia: a clinical review of 20 childhood cases. Acta Neurol. Scand. 77, 493–497 (1988).
  CAS PubMed Google Scholar
• Alikasifoglu, M. et al. Clinical and genetic correlate in childhood onset Friedreich ataxia. Neuropediatrics 30, 72–76 (1999).
  CAS PubMed Google Scholar
• Coppola, G. et al. Why do some Friedreich's ataxia patients retain tendon reflexes? A clinical, neurophysiological and molecular study. J. Neurol. 246, 353–357 (1999).
  CAS PubMed Google Scholar
• Hirai, T. et al. Neurological findings, neurophysiological examinations, and sural nerve biopsy in a case of Friedreich ataxia [Japanese]. Rinsho Shinkeigaku 46, 485–490 (2006).
  PubMed Google Scholar
• Santoro, L. et al. Relation between trinucleotide GAA repeat length and sensory neuropathy in Friedreich's ataxia. J. Neurol. Neurosurg. Psychiatry 66, 93–96 (1999).
  CAS PubMed PubMed Central Google Scholar
• Muller-Felber, W. et al. The clinical spectrum of Friedreich's ataxia in German families showing linkage to the FRDA locus on chromosome 9. Clin. Invest. 71, 109–114 (1993).
  CAS Google Scholar
• Santiago-Perez, S. et al. A neurophysiological study of the alterations to the central and peripheral nervous systems in Friedreich's ataxia [Spanish]. Rev. Neurol. 44, 193–197 (2007).
  CAS PubMed Google Scholar
• Santoro, L. et al. Influence of GAA expansion size and disease duration on central nervous system impairment in Friedreich's ataxia: contribution to the understanding of the pathophysiology of the disease. Clin. Neurophysiol. 111, 1023–1030 (2000).
  CAS PubMed Google Scholar
• Claus, D. et al. Central motor conduction in degenerative ataxic disorders: a magnetic stimulation study. J. Neurol. Neurosurg. Psychiatry 51, 790–795 (1988).
  CAS PubMed PubMed Central Google Scholar
• Mondelli, M. et al. Motor evoked potentials by magnetic stimulation in hereditary and sporadic ataxia. Electromyogr. Clin. Neurophysiol. 35, 415–424 (1995).
  CAS PubMed Google Scholar
• Lopez-Diaz-de-Leon, E. et al. Auditory neuropathy in Friedreich ataxia. A report of two cases. Int. J. Pediatr. Otorhinolaryngol. 67, 641–648 (2003).
  PubMed Google Scholar
• Mascalchi, M. et al. Friedreich's ataxia: MR findings involving the cervical portion of the spinal cord. AJR Am. J. Roentgenol. 163, 187–191 (1994).
  CAS PubMed Google Scholar
• Della Nave, R. et al. Brain structural damage in Friedreich's ataxia. J. Neurol. Neurosurg. Psychiatry 79, 82–85 (2008).
  CAS PubMed Google Scholar
• Casazza, F. & Morpurgo, M. The varying evolution of Friedreich's ataxia cardiomyopathy. Am. J. Cardiol. 77, 895–898 (1996).
  CAS PubMed Google Scholar
• Meyer, C. et al. Cardiomyopathy in Friedreich's ataxia—assessment by cardiac MRI. Mov. Disord. 22, 1615–1622 (2007).
  PubMed Google Scholar
• Kawai, C. et al. Heart disease in Friedreich's ataxia: observation of a case for half a century. Jpn. Circ. J. 64, 229–236 (2000).
  CAS PubMed Google Scholar
• Allard, P. et al. Pathomechanics and management of scoliosis in Friedreich ataxia patients: preliminary report. Can. J. Neurol. Sci. 7, 383–388 (1980).
  CAS PubMed Google Scholar
• Cady, R. B. & Bobechko, W. P. Incidence, natural history, and treatment of scoliosis in Friedreich's ataxia. J. Pediatr. Orthop. 4, 673–676 (1984).
  CAS PubMed Google Scholar
• Labelle, H. et al. Natural history of scoliosis in Friedreich's ataxia. J. Bone Joint Surg. Am. 68, 564–572 (1986).
  CAS PubMed Google Scholar
• Milbrandt, T. A. et al. Friedreich's ataxia and scoliosis: the experience at two institutions. J. Pediatr. Orthop. 28, 234–238 (2008).
  PubMed Google Scholar
• Beauchamp, M. et al. Natural history of muscle weakness in Friedreich's ataxia and its relation to loss of ambulation. Clin. Orthop. Relat. Res. 311, 270–275 (1995).
  Google Scholar
• Moseley, M. L. et al. Incidence of dominant spinocerebellar and Friedreich triplet repeats among 361 ataxia families. Neurology 51, 1666–1671 (1998).
  CAS PubMed Google Scholar
• Puccio, H. & Koenig, M. Friedreich ataxia: a paradigm for mitochondrial diseases. Curr. Opin. Genet. Dev. 12, 272–277 (2002).
  CAS PubMed Google Scholar
• Lodi, R. et al. Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia. Ann. Neurol. 49, 590–596 (2001).
  CAS PubMed Google Scholar
• Hart, P. E. et al. Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up. Arch. Neurol. 62, 621–626 (2005).
  PubMed Google Scholar
• Rustin, P. et al. Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study. Lancet 354, 477–479 (1999).
  CAS PubMed Google Scholar
• Hausse, A. O. et al. Idebenone and reduced cardiac hypertrophy in Friedreich's ataxia. Heart 87, 346–349 (2002).
  CAS PubMed PubMed Central Google Scholar
• Buyse, G. et al. Idebenone treatment in Friedreich's ataxia: neurological, cardiac, and biochemical monitoring. Neurology 60, 1679–1681 (2003).
  CAS PubMed Google Scholar
• Mariotti, C. et al. Idebenone treatment in Friedreich patients: one-year-long randomized placebo-controlled trial. Neurology 60, 1676–1679 (2003).
  CAS PubMed Google Scholar
• Ribai, P. et al. Neurological, cardiological, and oculomotor progression in 104 patients with Friedreich ataxia during long-term follow-up. Arch. Neurol. 64, 558–564 (2007).
  PubMed Google Scholar
• Pineda, M. et al. Idebenone treatment in paediatric and adult patients with Friedreich ataxia: long-term follow-up. Eur. J. Paediatr. Neurol. 12, 470–475 (2008).
  PubMed Google Scholar
• Schöls, L. et al. Idebenone in patients with Friedreich ataxia. Neurosci. Lett. 306, 169–172 (2001).
  PubMed Google Scholar
• Arnold, P. et al. Expanding view of phenotype and oxidative stress in Friedreich's ataxia patients with and without idebenone. Schweiz. Arch. Neurol. Psychiatr. 157, 169–175 (2006).
  Google Scholar
• Artuch, R. et al. Friedreich's ataxia: idebenone treatment in early stage patients. Neuropediatrics 33, 190–193 (2002).
  CAS PubMed Google Scholar
• Rustin, P. et al. Heart hypertrophy and function are improved by idebenone in Friedreich's ataxia. Free Radic. Res. 36, 467–469 (2002).
  CAS PubMed Google Scholar
• Di Prospero, N. A. et al. Safety, tolerability, and pharmacokinetics of high-dose idebenone in patients with Friedreich ataxia. Arch. Neurol. 64, 803–808 (2007).
  PubMed Google Scholar
• Di Prospero, N. A. et al. Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial. Lancet Neurol. 6, 878–886 (2007).
  CAS PubMed Google Scholar
• Schols, L. et al. L-carnitine and creatine in Friedreich's ataxia. A randomized, placebo-controlled crossover trial. J. Neural Transm. 112, 789–796 (2005).
  CAS PubMed Google Scholar
• Sorbi, S. et al. Double-blind, crossover, placebo-controlled clinical trial with L-acetylcarnitine in patients with degenerative cerebellar ataxia. Clin. Neuropharmacol. 23, 114–118 (2000).
  CAS PubMed Google Scholar
• Miller, E. R. 3rd et al. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann. Intern. Med. 142, 37–46 (2005).
  CAS PubMed Google Scholar
• Li, K. et al. Iron-dependent regulation of frataxin expression: implications for treatment of Friedreich ataxia. Hum. Mol. Genet. 17, 2265–2273 (2008).
  CAS PubMed PubMed Central Google Scholar
• Boddaert, N. et al. Selective iron chelation in Friedreich ataxia: biologic and clinical implications. Blood 110, 401–408 (2007).
  CAS PubMed Google Scholar
• Sohn, Y. S. et al. Redistribution of accumulated cell iron: a modality of chelation with therapeutic implications. Blood 111, 1690–1699 (2008).
  CAS PubMed Google Scholar
• Boesch, S. et al. Friedreich's ataxia: clinical pilot trial with recombinant human erythropoietin. Ann. Neurol. 62, 521–524 (2007).
  CAS PubMed Google Scholar
• Herman, D. et al. Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia. Nat. Chem. Biol. 2, 551–558 (2006).
  CAS PubMed Google Scholar
• Rai, M. et al. HDAC inhibitors correct frataxin deficiency in a Friedreich ataxia mouse model. PLoS ONE 3, e1958 (2008).
  PubMed PubMed Central Google Scholar
• Maring, J. R. & Croarkin, E. Presentation and progression of Friedreich ataxia and implications for physical therapist examination. Phys. Ther. 87, 1687–1696 (2007).
  PubMed Google Scholar
• American Physical therapy Association. Guide to Physical Therapist Practice, 2nd edn (American Physical Therapy Association, Alexandria, 2001).
• Delatycki, M. B. et al. Surgery for equinovarus deformity in Friedreich's ataxia improves mobility and independence. Clin. Orthop. Relat. Res. 430, 138–141 (2005).
  Google Scholar
• Harris-Love, M. O. et al. Rehabilitation management of Friedreich ataxia: lower extremity force-control variability and gait performance. Neurorehabil. Neural Repair 18, 117–124 (2004).
  PubMed Google Scholar
• Goulipian, C. et al. Orthopedic shoes improve gait in Friedreich's ataxia: a clinical and quantified case study. Eur. J. Phys. Rehabil. Med. 44, 93–98 (2008).
  CAS PubMed Google Scholar
• Ben Smail, D. et al. Intrathecal baclofen in the treatment of painful, disabling spasms in Friedreich's ataxia. Mov. Disord. 20, 758–759 (2005).
  PubMed Google Scholar
• Cardoso, E. S. et al. Botulinum toxin type A for the treatment of the spastic equinus foot in cerebral palsy. Pediatr. Neurol. 34, 106–109 (2006).
  PubMed Google Scholar
• Bateni, H. et al. Can use of walkers or canes impede lateral compensatory stepping movements? Gait Posture 20, 74–83 (2004).
  PubMed Google Scholar
• Fillyaw, M. J. & Ades, P. A. Endurance exercise training in Friedreich ataxia. Arch. Phys. Med. Rehabil. 70, 786–788 (1989).
  CAS PubMed Google Scholar
• Yorkston, K. M. et al. The effect of rate control on the intelligibility and naturalness of dysarthric speech. J. Speech Hear. Disord. 55, 550–560 (1990).
  CAS PubMed Google Scholar
• Sapir, S. et al. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on ataxic dysarthria: a case study. Am. J. Speech Lang. Pathol. 12, 387–399 (2003).
  PubMed Google Scholar
• Ramig, L. O. et al. Intensive voice treatment (LSVT) for patients with Parkinson's disease: a 2 year follow up. J. Neurol. Neurosurg. Psychiatry 71, 493–498 (2001).
  CAS PubMed PubMed Central Google Scholar
• Yorkston, K. M. et al. Extended communication samples of augmented communicators. I: A comparison of individualized versus standard single-word vocabularies. J. Speech Hear. Disord. 55, 217–224 (1990).
  CAS PubMed Google Scholar
• Fox, C. M. et al. The science and practice of LSVT/LOUD: neural plasticity-principled approach to treating individuals with Parkinson disease and other neurological disorders. Semin. Speech Lang. 27, 283–299 (2006).
  PubMed Google Scholar
• Corben, L. A. et al. Towards an understanding of cognitive function in Friedreich ataxia. Brain Res. Bull. 70, 197–202 (2006).
  PubMed Google Scholar
• White, M. et al. Neuropsychologic and neuropsychiatric characteristics of patients with Friedreich's ataxia. Acta Neurol. Scand. 102, 222–226 (2000).
  CAS PubMed Google Scholar
• Wessel, K. et al. Double-blind crossover study with levorotatory form of hydroxytryptophan in patients with degenerative cerebellar diseases. Arch. Neurol. 52, 451–455 (1995).
  CAS PubMed Google Scholar
• Wilson, C. L. et al. Quality of life in Friedreich ataxia: what clinical, social and demographic factors are important? Eur. J. Neurol. 14, 1040–1047 (2007).
  CAS PubMed Google Scholar
• D'Ambrosio, R. et al. Disability and quality of life in hereditary ataxias: a self-administered postal questionnaire. Int. Disabil. Stud. 9, 10–14 (1987).
  CAS PubMed Google Scholar
• Levent, K. et al. Anaesthesia for Friedreich's ataxia. Case report. Minerva Anestesiol. 66, 657–660 (2000).
  CAS PubMed Google Scholar
• Schmitt, H. J. et al. Rocuronium for muscle relaxation in two children with Friedreich's ataxia. Br. J. Anaesth. 92, 592–596 (2004).
  CAS PubMed Google Scholar
• Kam, P. C. & Cardone, D. Propofol infusion syndrome. Anaesthesia 62, 690–701 (2007).
  CAS PubMed Google Scholar
• Short, T. G. & Young, Y. Toxicity of intravenous anaesthetics. Best Pract. Res. Clin. Anaesthesiol. 17, 77–89 (2003).
  CAS PubMed Google Scholar
• Bruner, J. P. & Yeast, J. D. Pregnancy associated with Friedreich ataxia. Obstet. Gynecol. 76, 976–977 (1990).
  CAS PubMed Google Scholar
• Fogel, B. L. & Perlman, S. Clinical features and molecular genetics of autosomal recessive cerebellar ataxias. Lancet Neurol. 6, 245–257 (2007).
  CAS PubMed Google Scholar
• Mukerji, M. et al. Molecular analysis of Friedreich's ataxia locus in the Indian population. Acta Neurol. Scand. 102, 227–229 (2000).
  CAS PubMed Google Scholar